Wealth Enhancement Advisory Services’s Boston Scientific BSX Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$640K	Hold	15,000	–	–	﹤0.01%	2458
2026 Q1	$11M	Hold	15,000	–	–	0.02%	556
2025 Q4	$75K	Hold	15,000	–	–	﹤0.01%	3486
2025 Q3	$94.5K	Hold	15,000	–	–	﹤0.01%	3344
2025 Q2	$80.4K	Hold	15,000	–	–	﹤0.01%	3173
2025 Q1	$104K	Buy	+15,000	New	+$1.51M	﹤0.01%	2755

Other funds holding BSX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

FFM

Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

ZIC

ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return

Wealth Enhancement Advisory Services's BSX Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Boston Scientific (BSX) stake by 39% in Q2 2026, buying an estimated $3.8M and bringing the position to 249,780 shares worth $10.7M. The position accounts for 0.02% of the portfolio, ranked #648.

Wealth Enhancement Advisory Services first reported a position in BSX in Q4 2016 and has held it in 15 quarters since. The position peaked at $13.3M in Q3 2024. 303 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Wealth Enhancement Advisory Services held 249,780 shares of Boston Scientific worth $10.7M as of Q2 2026.
Wealth Enhancement Advisory Services bought 70,056 Boston Scientific shares in Q2 2026, an estimated $3.8M.
Boston Scientific made up 0.02% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #648 holding.
Wealth Enhancement Advisory Services first reported a position in Boston Scientific in Q4 2016 and has held it in 15 quarters since.
Wealth Enhancement Advisory Services's Boston Scientific position peaked at $13.3M in Q3 2024.
303 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.